Wisdom and Wagers: Perspectives from Big Pharma Dealmakers

11:00 AM - 12:00 PM (PDT), Wednesday, June 15, 2022 ・ Upper Level, Session Room 6F

Join some of Pharma’s biggest dealmakers as they discuss the challenges, opportunities, and trends that will alter the partnering landscape in the coming years. Each panelist is in their company’s hot seat to find potential breakthroughs for patients and deliver value to partners and shareholders alike.  Covering topics from pandemics and patent cliffs to biotech valuations and bolt-on acquisitions, this session will provide insight about the mindset needed for delivering deals in an uncertain market. Hear the therapeutic areas and technologies where our panelists are placing their bets, their strategies for mitigating risk, and what partnership success looks like to them at the end of the day.

Moderator
photo
Partner
PricewaterhouseCoopers, LLP
Speakers
photo
SrVP, Oncology, Hematology, Cell Therapy Medicine
Bristol Myers Squibb
photo
Vice President, Search and Evaluation
AbbVie Inc.
photo
Business Development Group Lead, Internal Medicine and Vaccines
Pfizer
photo
Vice President, Business Development & Licensing; Head, Oncology Business Development & Headquarters Transactions
Merck